A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer

Oncogene
Anne Y WarrenMohammad Asim

Abstract

Elucidation of mechanisms underlying the increased androgen receptor (AR) activity and subsequent development of aggressive prostate cancer (PrCa) is pivotal in developing new therapies. Using a systems biology approach, we interrogated the AR-regulated proteome and identified PDZ binding kinase (PBK) as a novel AR-regulated protein that regulates full-length AR and AR variants (ARVs) activity in PrCa. PBK overexpression in aggressive PrCa is associated with early biochemical relapse and poor clinical outcome. In addition to its carboxy terminus ligand-binding domain, PBK directly interacts with the amino terminus transactivation domain of the AR to stabilise it thereby leading to increased AR protein expression observed in PrCa. Transcriptome sequencing revealed that PBK is a mediator of global AR signalling with key roles in regulating tumour invasion and metastasis. PBK inhibition decreased growth of PrCa cell lines and clinical specimen cultured ex vivo. We uncovered a novel interplay between AR and PBK that results in increased AR and ARVs expression that executes AR-mediated growth and progression of PrCa, with implications for the development of PBK inhibitors for the treatment of aggressive PrCa.

References

Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·S GaudetR A Lue
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Sep 17, 2004·Endocrine-related Cancer·Howard I ScherWayne D Tilley
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
May 8, 2007·Biochemical and Biophysical Research Communications·Asit K NandiAaron P Rapoport
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Nupam P MahajanYoung E Whang
Mar 18, 2009·Bioinformatics·Cole TrapnellSteven L Salzberg
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhardt AttardJohann S de Bono
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Oct 29, 2010·Genome Biology·Simon Anders, Wolfgang Huber
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 24, 2012·Cancer Research·Dong Joon KimZigang Dong
Jun 23, 2012·Nature·Catherine S GrassoScott A Tomlins
Dec 15, 2012·Leukemia Research·Fang HuAaron P Rapoport
Dec 22, 2012·The Journal of Clinical Investigation·Michael A AugelloKaren E Knudsen
Jun 1, 2013·The Journal of Clinical Investigation·Jae-Kyung MyungMarianne D Sadar
Oct 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Michael D NyquistScott M Dehm
Sep 4, 2014·The New England Journal of Medicine·Emmanuel S AntonarakisJun Luo
Sep 28, 2014·Bioinformatics·Simon AndersWolfgang Huber
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Nov 18, 2015·European Urology·Greg L ShawDavid E Neal
Dec 15, 2015·Journal of the National Cancer Institute·Mohammad AsimDavid E Neal
May 31, 2016·Cancer Cell·Anna C GronerMyles Brown
Aug 31, 2017·Nature Communications·Mohammad AsimThomas Helleday

❮ Previous
Next ❯

Methods Mentioned

BETA
immunoprecipitation
pull-down
co-immunoprecipitation
RNAseq
transfection
amidation
transfections
biopsy

Software Mentioned

Sequest
Mascot
TopHat
count
HTSeq
DESeq
Bioconductor
Image J
Thermo Proteome Discoverer
DAVID

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.